To understand the role of αVβ6 integrin in HER2+ breast cancer progression, we sought to define the composition of the signaling networks recruited to ligand-bound αVβ6, “the αVβ6 integrin adhesome,” in HER2+ breast cancer cells. This evidence concerns the gene ERBB2 and breast cancer.